Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats
Maricarmen Hernández‐Rodríguez, Ivonne Maciel Arciniega-Martínez, Iohanan Daniel García-Marín, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 9, pp. 3979-3988
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
Elena Tamagno, Michela Guglielmotto, Valeria Vasciaveo, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1479-1479
Open Access | Times Cited: 149
Reimagining cholinergic therapy for Alzheimer’s disease
Ezio Giacobini, A. Claudio Cuello, Abraham Fisher
Brain (2022) Vol. 145, Iss. 7, pp. 2250-2275
Open Access | Times Cited: 111
Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer’s disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway
Sha Sha, Xueli Shen, Yunpeng Cao, et al.
Aging (2021)
Open Access | Times Cited: 64
Oxygen metabolism abnormality and Alzheimer's disease: An update
Guangdong Liu, Cui Yang, Xin Wang, et al.
Redox Biology (2023) Vol. 68, pp. 102955-102955
Open Access | Times Cited: 26
A comprehensive investigation of Clerodendrum Infortunatum Linn. using LC-QTOF-MS/MS metabolomics as a promising anti-alzheimer candidate
Fatma Atef, Mostafa A. Abdelkawy, Basma M. Eltanany, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Decoding the Role of Neurotrophins in Glycogen Synthase Kinase 3-Beta Regulation in Alzheimer’s Disease
Shubham Nilkanth Rahmatkar, Damanpreet Singh
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Insights into the neuroprotective effects ofSalvia officinalisL. andSalvia microphyllaKunth in the memory impairment rat model
Iriny M. Ayoub, Mina Y. George, Esther T. Menze, et al.
Food & Function (2022) Vol. 13, Iss. 4, pp. 2253-2268
Closed Access | Times Cited: 38
Tropane alkaloids (hyoscyamine, scopolamine and atropine) from genus Datura: extractions, contents, syntheses and effects
Zhiwen Shi, Wenjin Zou, Zhiming Zhu, et al.
Industrial Crops and Products (2022) Vol. 186, pp. 115283-115283
Closed Access | Times Cited: 30
Saffron (Crocus sativus L.) extract attenuates chronic scopolamine-induced cognitive impairment, amyloid beta, and neurofibrillary tangles accumulation in rats
Komal Patel, Abhay Dharamsi, Madhu Priya, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117898-117898
Closed Access | Times Cited: 8
Curculigoside, a traditional Chinese medicine monomer, ameliorates oxidative stress in Alzheimer's disease mouse model via suppressing ferroptosis
Yuhang Gong, Yanan Wang, Yanfeng Li, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2462-2481
Closed Access | Times Cited: 7
Thymus vulgaris Essential Oil Protects Zebrafish against Cognitive Dysfunction by Regulating Cholinergic and Antioxidants Systems
Luminita Capatina, Elena Todirașcu-Ciornea, Edoardo Napoli, et al.
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1083-1083
Open Access | Times Cited: 47
Minocycline attenuates cholinergic dysfunction and neuro-inflammation-mediated cognitive impairment in scopolamine-induced Alzheimer’s rat model
Sabiheh Amirahmadi, Faezeh Dabouri Farimani, Mahsan Akbarian, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2385-2397
Closed Access | Times Cited: 20
Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer’s disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB
Sally A. Abuelezz, Nevien Hendawy
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 8, pp. 1119-1129
Closed Access | Times Cited: 11
Neuroprotective Effect of Saroglitazar on Scopolamine-Induced Alzheimer’s in Rats: Insights into the Underlying Mechanisms
Grandhi Sandeep Ganesh, Prasad Konduri, Aravinda Sai Kolusu, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 18, pp. 3444-3459
Closed Access | Times Cited: 11
Scopolamine affects fear learning and social recognition in adult zebrafish
Chih‐Wei Fu, Sok‐Keng Tong, Mingxin Liu, et al.
Neuroscience (2025)
Closed Access
Pomegranate Seed Oil Boosts Memory by Reducing Amyloid Plaques and Restoring Neuronal Density in Alzheimer’s Model Rats
Mehrdad Jahanshahi, Vahid Khori, Emsehgol Nikmahzar, et al.
Jundishapur Journal of Natural Pharmaceutical Products (2025) Vol. 20, Iss. 2
Open Access
Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease
Xueyan Liu, Chuanyu Yu, Yuxing Yao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115120-115120
Closed Access | Times Cited: 10
Alleviative effect of scopolamine‑induced memory deficit via enhancing antioxidant and cholinergic function in rats by pinostrobin from Boesenbergia rotunda (L.)
Sitthisak Thongrong, Tichanon Promsrisuk, Napatr Sriraksa, et al.
Biomedical Reports (2024) Vol. 21, Iss. 3
Open Access | Times Cited: 3
Ablation of ST6Gal-I Downregulates BACE1 Expression and Suppresses Production of Aβ42 Plaques in Alzheimer’s Disease
Kangkang Yang, Xueying Li, Minchao Lai, et al.
Engineering (2025)
Open Access
Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer’s disease in rats: role of AMPK/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress
Ebtsam S Abdel-Lah, Hoda S. Sherkawy, Wafaa H. Mohamed, et al.
Inflammopharmacology (2025)
Open Access
Combination of Polygoni Multiflori Radix Praeparata and Acori Tatarinowii Rhizoma Alleviates Learning and Memory Impairment in Scopolamine-Treated Mice by Regulating Synaptic-Related Proteins
Funan Ning, Lvyi Chen, Linlin Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
Ginsenoside compound K reduces neuronal damage and improves neuronal synaptic dysfunction by targeting Aβ
Na Li, Qihang Pang, Yanhong Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Montelukast Ameliorates Scopolamine-induced Alzheimer’s Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF
Bhavana Yerraguravagari, Naga Pavani Penchikala, Aravinda Sai Kolusu, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 8, pp. 1040-1055
Closed Access | Times Cited: 7
Dihydroergotamine Increases Histamine Brain Levels and Improves Memory in a Scopolamine-Induced Amnesia Model
Maricarmen Hernández‐Rodríguez, Elvia Mera Jiménez, María Inés Nicolás‐Vázquez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3710-3710
Open Access | Times Cited: 2
Euonymus hamiltonianus Extract Improves Amnesia in APPswe/Tau Transgenic and Scopolamine-Induced Dementia Models
Hyosun Choi, Joonki Kim, Sangbin Lee, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10845-10860
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top